Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sixth Wave Innovations Inc SIXWF

Sixth Wave Innovations Inc. is a Canada-based nanotechnology company with patented technologies. The Company is focused on the extraction and detection of target substances at the molecular level using specialized molecularly imprinted polymers (MIPs). The Company’s product brands include AMIPs, IXOS and Affinity. The IXOS is a line of extraction polymers formulated for deployment in the gold mining industry. The Affinity system is using its MIPs, which are designed to capture and extract cannabinoids from filtered crude extracts without the use of traditional winterization and distillation. The Company’s patent portfolio covers extensions of the designs for extraction and purification of other critical metals including nickel, cobalt, rare earth elements, and platinum group metals. It also designs, develops and commercializes MIP solutions across a spectrum of industries.


GREY:SIXWF - Post by User

Post by Tony001on Mar 29, 2021 9:38am
168 Views
Post# 32897441

Good thoughts

Good thoughts
Good thoughts, although 100$ for a mask seems much too high to me. I think the pricing will be more in the region of $10, where SIXW could still make a huge profit. 
 
Regarding valuation, there is a company in Switzerland, Relief Therapeutics, that has a drug in the pipeline that can be used to treat severe covid symptoms. However, it is highly uncertain whether the drug will ever be put to market. Moreover, the benefits of such a drug are very limited. The pre-Covid valuation was in the range of USD 10 million. Today, the valuation is just under one billion USD. Is SIXW worth as much or even more? Perhaps. Is SIXW worth more than today's valuation suggests?  Without a doubt.
<< Previous
Bullboard Posts
Next >>